Realizing the potential for Epitopix intellectual property in combating human disease, Epitopix and WPC formed Syntiron to adapt the Epitopix SRP technology to the development of human vaccines.
Realizing the potential for Epitopix intellectual property in combating human disease, Epitopix and WPC formed Syntiron to adapt the Epitopix SRP technology to the development of human vaccines.